Genprex (GNPX) Prices 7.62M Share Common Offering at $1.05/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Genprex (GNPX) Adds to Tuesday's Big Gains on FDA News; Shares Up 60%
January 22, 2020 8:33 AM ESTGenprex (NASDAQ: GNPX) adds to Tuesday gains after the company received DA Fast Track designation for its gene therapy that targets lung cancer. Shares are up 64% pre-open after gaining 219% on Tuesday.
... MoreGenprex (GNPX) Granted FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer
January 21, 2020 8:01 AM ESTGenprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor... More
